GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Modern Mobility Aids Inc (OTCPK:MDRM) » Definitions » Intrinsic Value: Projected FCF

Modern Mobility Aids (Modern Mobility Aids) Intrinsic Value: Projected FCF : $0.00 (As of Jun. 04, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Modern Mobility Aids Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-06-04), Modern Mobility Aids's Intrinsic Value: Projected FCF is $0.00. The stock price of Modern Mobility Aids is $0.0059. Therefore, Modern Mobility Aids's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Modern Mobility Aids's Intrinsic Value: Projected FCF or its related term are showing as below:

MDRM's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.26
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Modern Mobility Aids Intrinsic Value: Projected FCF Historical Data

The historical data trend for Modern Mobility Aids's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modern Mobility Aids Intrinsic Value: Projected FCF Chart

Modern Mobility Aids Annual Data
Trend Jun10 Jun11 Jun12 Jun13 Jun14
Intrinsic Value: Projected FCF
- - - - -

Modern Mobility Aids Quarterly Data
Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Modern Mobility Aids's Intrinsic Value: Projected FCF

For the Health Information Services subindustry, Modern Mobility Aids's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Modern Mobility Aids's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Modern Mobility Aids's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Modern Mobility Aids's Price-to-Projected-FCF falls into.



Modern Mobility Aids Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Modern Mobility Aids  (OTCPK:MDRM) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Modern Mobility Aids's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.0059/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Modern Mobility Aids Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Modern Mobility Aids's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Modern Mobility Aids (Modern Mobility Aids) Business Description

Traded in Other Exchanges
N/A
Address
79 Bramsteele Road, Brampton, ON, CAN, L6W3K6
Modern Mobility Aids Inc plays a vital role in fostering telehealth innovation, driving technological advancements, and improving access to healthcare services. It is focused on investing in people, products, and ventures that challenge and disrupt the telehealth category.